Discovering and Developing Recombinant Molecular Scavenging Agents for the Treatment of Carbon Monoxide Induced Cardiovascular Dysfunction
发现和开发用于治疗一氧化碳引起的心血管功能障碍的重组分子清除剂
基本信息
- 批准号:10442531
- 负责人:
- 金额:$ 2.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesAffinityAnimal Disease ModelsAntidotesBindingBiological AssayBiologyBlood PressureBusinessesCarbon MonoxideCarbon Monoxide PoisoningCarboxyhemoglobinCardiacCardiac MyocytesCardiovascular PhysiologyCardiovascular systemCathetersClinicalClinical ResearchComplexCritical CareDevelopmentDisease modelDrug DesignDrug KineticsDrug TargetingEffectivenessElectrodesElectron TransportElementsEngineeringEnvironmentErythrocytesExposure toFunctional disorderGenerationsGlobinGlycolysisGoalsHeartHeart RateHemeHemoglobinHumanHyperbaric OxygenHypersensitivityImplantIn VitroIndividualInterventionIntravenousK-Series Research Career ProgramsLeadLevel of EvidenceLungMeasuresMechanical ventilationMediatingMedicineMentorsMentorshipMethodsMitochondriaModelingMolecularMorbidity - disease rateMusMyocardial dysfunctionMyoglobinNeurocognitive DeficitOxidative PhosphorylationOxygenPatient CarePatientsPeptidesPeroxidasesPersonsPharmacologyPhysiciansPhysiologicalPoisoningPositioning AttributeProcessProductionProgram DevelopmentPropertyProteinsRecombinantsRecording of previous eventsResearchResearch InfrastructureResearch PersonnelResearch TrainingRespirationRodent ModelRoleSafetySchoolsScientistSurvivorsSystemSystems AnalysisTechniquesTestingTissuesToxic effectToxicologyTrainingUnited StatesUniversitiesWorkassay developmentautooxidationbasecardiac depressioncardiovascular effectscareercohesioncommercializationcytochrome c oxidasedepressive symptomsdesigndrug developmentdrug discoveryefficacy testingexperienceexperimental studyextracellularheme ahemodynamicshigh riskhuman diseasehypoperfusionimprovedin vivoinnovationmanufacturing processmitochondrial dysfunctionmolecular sizemortalitymortality riskmouse modelmultitaskmutantmyocardial injuryneuroglobinnext generationnovelnovel therapeuticspeptide Bperoxidationprofessorprogramsrestorationskillssmall moleculetissue respiration
项目摘要
Project Summary/Abstract
Dr. Jason Rose is resubmitting this application for a Mentored Research Career Development Award entitled
“Discovering and Developing Recombinant Molecular Scavenging Agents for the Treatment of Carbon Monoxide
(CO) Induced Cardiovascular Dysfunction”. Dr. Rose is a pulmonary and critical care physician, and now,
Assistant Professor of Medicine at the University of Pittsburgh seeking additional training in molecular
engineering, mitochondrial biology, animal models of disease, and drug discovery to further develop into an
independent research investigator. His long-term goal is to lead large academic drug design, discovery and
development programs. His short-term training goals, for this proposal, are to: (1) acquire proficiency in the
assessment of cardiovascular pathophysiology in animal models of disease and develop the skillset to become
a primary investigator in studying the role of mitochondrial dysfunction in human disease; (2) gain expertise in
molecular engineering, targeted drug design and drug discovery assay development; and (3) develop the
management skills to become an expert in the early-stage development of new therapeutics. Building on his
recent graduation from the Tepper School of Business MBA program, he will supplement his training with didactic
courses in molecular pharmacology, drug discovery and cardiovascular physiology. He has assembled experts
in drug discovery, cardiovascular dynamics, and mitochondrial biology to form a cohesive mentor team and
scientific advisory committee. The proposed work will be conducted within the Division of Pulmonary, Allergy,
and Critical Care at the University of Pittsburgh, which has a strong history of training physician scientists and
provides a superb infrastructure for his research and his path to academic independence.
CO exposure is the leading cause of poisoning in the world and there is no antidote to CO. Current interventions
have limited effectiveness: new therapies are needed. The central objective of this proposal is to further identify
and develop an antidotal therapy for CO poisoning. Aim 1 will focus on establishing the mechanisms of CO-
induced cardiovascular toxicity: investigating CO-induced mitochondrial inhibition and measuring hemodynamics
in a severe CO poisoning mouse model. Aim 2 will test the efficacy and safety of recombinant neuroglobin to
reverse the molecular and cardiac dysfunction caused by CO toxicity. Aim 3 will seek to identify novel heme
containing molecules as CO scavengers, using a new manufacturing process and discovery assays. Although
this proposal is ambitious, Dr. Rose has now completed his MBA degree during his intense clinical and research
training demonstrating his ability to multitask in the academic environment. The combination of (1) formal training
in cardiovascular physiology, innovation and molecular pharmacology; (2) novel research experience that
includes disease modeling, drug development and discovery elements; (3) an experienced, diverse mentorship
team and advisory committee; and (4) the strong institutional environment at the University of Pittsburgh will
equip Dr. Rose for a career as an independent research investigator and academic drug discovery leader.
项目总结/摘要
博士Jason Rose正在重新提交这份申请,申请一个名为“指导研究职业发展奖”的项目。
“发现和开发用于治疗一氧化碳的重组分子清除剂
(CO)诱发心血管功能障碍”。罗斯医生是一名肺病和重症监护医生,现在,
匹兹堡大学医学助理教授,寻求分子生物学方面的额外培训
工程,线粒体生物学,疾病的动物模型,和药物发现,以进一步发展成为一个
独立调查员。他的长期目标是领导大型学术药物设计,发现和开发。
发展方案。他的短期培训目标,对于这个建议,是:(1)获得熟练的
在疾病的动物模型中评估心血管病理生理学,并发展成为
研究线粒体功能障碍在人类疾病中的作用的主要研究者;(2)获得以下方面的专业知识
分子工程、靶向药物设计和药物发现分析开发;以及(3)开发
管理技能,成为新疗法早期开发的专家。根据他
最近从泰珀商学院MBA课程毕业,他将补充他的培训与说教
分子药理学、药物发现和心血管生理学课程。他召集了专家
在药物发现,心血管动力学和线粒体生物学方面,形成一个有凝聚力的导师团队,
科学顾问委员会。拟议的工作将在肺、过敏、
和匹兹堡大学的重症监护,该大学在培养医生科学家方面有着悠久的历史,
为他的研究和学术独立提供了极好的基础设施。
接触一氧化碳是世界上导致中毒的主要原因,目前没有一氧化碳的解毒剂。
有效性有限:需要新的治疗方法。本建议的核心目标是进一步查明
开发一种一氧化碳中毒的解毒疗法目标1将侧重于建立CO-
诱导的心血管毒性:研究CO诱导的线粒体抑制并测量血流动力学
在严重CO中毒小鼠模型中。目的2将测试重组脑红蛋白对脑缺血再灌注损伤的有效性和安全性。
逆转由CO毒性引起的分子和心脏功能障碍。目标3将寻求确定新的血红素
含有分子作为CO清除剂,使用新的制造工艺和发现分析。虽然
这个计划是雄心勃勃的,罗斯博士现在已经完成了他的MBA学位,在他紧张的临床和研究
培训展示了他在学术环境中处理多项任务的能力。(1)正规培训
在心血管生理学、创新和分子药理学方面;(2)新的研究经验,
包括疾病建模,药物开发和发现元素;(3)经验丰富,多样化的指导
团队和咨询委员会;(4)匹兹堡大学强大的制度环境将
装备罗斯博士的职业生涯作为一个独立的研究调查员和学术药物发现的领导者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jason J Rose其他文献
Jason J Rose的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jason J Rose', 18)}}的其他基金
University of Maryland BaltImore Life Science Discovery (UM-BILD) Accelerator
马里兰大学巴尔的摩生命科学发现 (UM-BILD) 加速器
- 批准号:
10783358 - 财政年份:2023
- 资助金额:
$ 2.06万 - 项目类别:
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning
用于治疗一氧化碳中毒的血红蛋白解毒剂
- 批准号:
10282997 - 财政年份:2020
- 资助金额:
$ 2.06万 - 项目类别:
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning
用于治疗一氧化碳中毒的血红蛋白解毒剂
- 批准号:
10296690 - 财政年份:2020
- 资助金额:
$ 2.06万 - 项目类别:
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning
用于治疗一氧化碳中毒的血红蛋白解毒剂
- 批准号:
9908358 - 财政年份:2020
- 资助金额:
$ 2.06万 - 项目类别:
Discovering and Developing Recombinant Molecular Scavenging Agents for the Treatment of Carbon Monoxide Induced Cardiovascular Dysfunction
发现和开发用于治疗一氧化碳引起的心血管功能障碍的重组分子清除剂
- 批准号:
10213117 - 财政年份:2018
- 资助金额:
$ 2.06万 - 项目类别:
Developing a Low-Cost Intelligent Ventilator with Remote Control for Rapid, Global Deployment and Minimal Healthcare Provider Exposure
开发具有远程控制功能的低成本智能呼吸机,以实现快速全球部署并最大限度地减少医疗保健提供者的暴露
- 批准号:
10166226 - 财政年份:2018
- 资助金额:
$ 2.06万 - 项目类别:
Discovering and Developing Recombinant Molecular Scavenging Agents for the Treatment of Carbon Monoxide Induced Cardiovascular Dysfunction
发现和开发用于治疗一氧化碳引起的心血管功能障碍的重组分子清除剂
- 批准号:
9973110 - 财政年份:2018
- 资助金额:
$ 2.06万 - 项目类别:
Carbon Monoxide Inhibition of Mitochondrial Function and Efficacy of a Novel Antidotal Therapeutic for Carbon Monoxide Poisoning
一氧化碳对线粒体功能的抑制以及新型一氧化碳中毒解毒疗法的功效
- 批准号:
9121057 - 财政年份:2016
- 资助金额:
$ 2.06万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 2.06万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 2.06万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 2.06万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 2.06万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 2.06万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 2.06万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 2.06万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 2.06万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 2.06万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 2.06万 - 项目类别:
Continuing Grant